#TTFields
LightNews LightNews
oncodaily.bsky.social
ESMO - Do OS, QoL and Pain Management Data Favour the Use of TTFields For the Treatment of LAPAC?
@myesmo.bsky.social

oncodaily.com/opinion/pain...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Do OS, QoL and Pain Management Data Favour the Use of TTFields For the Treatment of LAPAC? - ESMO - OncoDaily
Do OS, QoL and Pain Management Data Favour the Use of TTFields For the Treatment of LAPAC? - ESMO / Angela Lamarca, ESMO, ESMO - European Society for Medical
oncodaily.com
July 30, 2025 at 11:20 PM
oncodaily.bsky.social
ESMO GI 2025 Highlights: PANOVA-3 Trial on TTFields + GnP in Unresectable LAPC
@myesmo.bsky.social

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMOGI25 #PANOVA3 #LAPC
PANOVA-3 Trial on TTFields + GnP in LAPC: ESMO GI 2025
The PANOVA-3 trial (NCT03377491) at ESMO GI 2025 showed that TTFields + GnP improves pain, symptoms, and quality of life in LAPC.
oncodaily.com
July 4, 2025 at 6:19 PM
brainnetleipzig.bsky.social
🚨 New paper alert from Weise et al.!

"A leadfield-free optimization framework for transcranially applied electric currents"

🔋 Optimize TES, TIS, ECT & TTFields without fixed leadfields
🧠 Electrode placement adapts to individual anatomy
💻 Now available in SimNIBS!

doi.org/10.1016/j.co...
July 2, 2025 at 7:57 AM
palishpacobb.bsky.social
Seeing new options like TTFields for pancreatic cancer is so cool. I love that research is tackling it from different angles, like how early trials testing vopimetostat with daraxonrasib showed 11 out of 12 evaluable patients having an objective response. Every bit of progress counts.
September 29, 2026 at 6:11 AM
louisslesin.bsky.social
Optune uses 150 kHz TTFields with electric-field intensity ~100s V/m. ICNIRP exposure limits assume such fields would have *no* health effects, and would certainly not disrupt cancer cells. Indeed, the ICNIRP occupational and general population limits are ~10x higher!
bsky.app/profile/micr...
microwavenews.com Microwave News @microwavenews.com · Feb 13
Optune Pax is a wearable medical device that delivers Tumor Treating Fields (TTFields), alternating electric fields that disrupt cancer cell replication to cause cell death, providing a new treatment approach for pancreatic tumors.
www.novocure.com/us-fda-appro...
February 13, 2026 at 5:16 PM
syedaahmad5.bsky.social
Results of PANOVA-3 trial is positive. 👇🏼👇🏼

www.biospace.com/press-releas...
Novocure Announces Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer
www.biospace.com
December 2, 2024 at 4:04 PM
ascocancer.bsky.social
Dr. Nina Sanford discusses the PANOVA-3 trial, which found an improvement in OS for pts w unresectable, locally adv pancreatic adenocarcinoma treated in the first line w TTFields concomitant w gemcitabine & nab-paclitaxel. #ASCO25

Learn more: www.asco.org/abstracts-pr...
May 31, 2025 at 9:50 PM
diariocordoba.com
La oncóloga radioterapéutica del hospital Reina Sofía Sonia García destaca que esta estrategia terapéutica ha demostrado en ensayos clínicos una mejora en la supervivencia frente al glioblastoma
Córdoba comienza a aplicar la terapia TTFields: el objetivo es ralentizar la evolución de un tumor cerebral muy agresivo
www.diariocordoba.com
October 3, 2026 at 5:23 PM
laurabensonrn.bsky.social
Good news for pancreatic cancer patients : www.clinicaltrialsarena.com/news/novocur...
Novocure seeks approval after pancreatic cancer wearable scores at Phase III
Novocure’s TTFields therapy combined with chemo improved overall survival by 16.2 months compared to 14.16 months with chemo alone.
www.clinicaltrialsarena.com
December 3, 2024 at 12:59 AM
diariocordoba.com
La oncóloga radioterapéutica del hospital Reina Sofía Sonia García destaca que esta estrategia terapéutica ha demostrado en ensayos clínicos una mejora en la supervivencia frente al glioblastoma
Córdoba comienza a aplicar la terapia TTFields: el objetivo es ralentizar la evolución de un tumor cerebral muy agresivo
www.diariocordoba.com
October 2, 2026 at 10:49 AM
microwavenews.com
Optune Pax is a wearable medical device that delivers Tumor Treating Fields (TTFields), alternating electric fields that disrupt cancer cell replication to cause cell death, providing a new treatment approach for pancreatic tumors.
www.novocure.com/us-fda-appro...
February 13, 2026 at 1:42 AM
cancerassassin1.bsky.social
Sharing our newest publication in STAR Protocols @cellpress.bsky.social: Protocol for applying Tumor Treating Fields in mouse models of cancer using the inovivo system star-protocols.cell.com/protocols/3946 TTFields are in use for multiple cancer types; this paper outlines in vivo investigation.
January 9, 2025 at 4:31 PM
diariocordoba.com
Este paciente del Reina Sofía, junto a otras cuatro enfermos, son los primeros en recibir en Córdoba una nueva terapia, financiada por el SAS, para tratar de ralentizar la evolución del glioblastoma multiforme, un agresivo tumor cerebral
Luis Diego, paciente beneficiario en Córdoba del tratamiento TTFields: 'Parece que me está yendo bien porque no deja avanzar los tumores'
www.diariocordoba.com
October 3, 2026 at 5:02 PM
lgoodbu.bsky.social
rarecancernews.com/news/electri...
Electrical therapy shows promise for metastatic pancreatic cancer
Electrical therapy TTFields along with other medications may halt disease progression in metastatic pancreatic cancer, per trial data.
rarecancernews.com
April 5, 2026 at 7:57 AM
earthmother30.bsky.social
shorturl.at/Fw5s0 Uses combo with gemcitabine & nab-paclitaxel. Optune Pax delivers alternating electrical fields, known as tumor treating fields (TTFields), to the abdomen. TTFields work by disrupting the rapid cell division characteristic of cancer cells, causing cell death.
FDA Approves Wearable Device to Treat Pancreatic Cancer
The manufacturer says the approval is the first for locally advanced pancreatic cancer in 30 years.
shorturl.at
February 20, 2026 at 2:49 AM
grnfluoresceblg.bsky.social
Another cool-looking paper on #tunnelingnanotubes
🧪🔬
elifesciences.org/articles/853...
Treatment with tumor-treating fields (TTFields) suppresses intercellular tunneling nanotube formatio...
Cancer-directed treatment using Tumor-Treating Fields spatially modulates the tumor microenvironment at the cellular and molecular levels, decreasing nanotube-based cellular networks of communication ...
elifesciences.org
November 17, 2023 at 11:03 PM
diariocordoba.com
Este paciente del Reina Sofía, junto a otras cuatro enfermos, son los primeros en recibir en Córdoba una nueva terapia, financiada por el SAS, para tratar de ralentizar la evolución del glioblastoma multiforme, un agresivo tumor cerebral
Luis Diego, paciente beneficiario en Córdoba del tratamiento TTFields: 'Parece que me está yendo bien porque no deja avanzar los tumores'
www.diariocordoba.com
October 2, 2026 at 4:49 PM
keck.usc.edu
Researchers at @keckmedicineusc.bsky.social found that Tumor Treating Fields (TTFields), a therapy that uses electric fields to disrupt tumor growth, may help patients with glioblastoma live longer when combined with immunotherapy and chemotherapy.

#CancerResearch #MedSky
USC study unlocks new potential treatment for glioblastoma
LOS ANGELES — A new study led by Keck Medicine of USC researchers may have uncovered an effective combination therapy for glioblastoma, a brain tumor diagnosis with few available effective treatments....
news.keckmedicine.org
September 26, 2025 at 5:35 PM
onclive.bsky.social
Addition of TTFields to Gemcitabine/Nab-Paclitaxel Boosts OS in Locally Advanced PDAC @ascocancer.bsky.social #ASCO25 www.onclive.com/view/additio...
Addition of TTFields to Gemcitabine/Nab-Paclitaxel Boosts OS in Locally Advanced PDAC
TTFields plus chemotherapy improved overall survival in unresectable, locally advanced pancreatic ductal adenocarcinoma.
www.onclive.com
June 1, 2025 at 12:26 PM
onclive.bsky.social
TTFields Plus Chemo Improves QOL, Delays Time to Pain Deterioration in Locally Advanced Pancreatic Adenocarcinoma @myesmo.bsky.social #ESMOGI25 #medtwitter #oncology www.onclive.com/view/ttfield...
TTFields Plus Chemo Improves QOL, Delays Time to Pain Deterioration in Locally Advanced Pancreatic Adenocarcinoma
The addition of TTFields to chemotherapy improved quality of life and delayed time to pain deterioration in locally advanced pancreatic cancer.
www.onclive.com
July 3, 2025 at 8:18 PM
patrickforde.bsky.social
Interesting…second line lung cancer trial positive (with caveats), now first line pancreatic cancer. Need to see the paper but TTF is here to stay it seems. Positive Topline Results from Phase 3 PANOVA-3Trial of Tumor Treating Fields for Pancreatic Ca.
www.businesswire.com/news/home/20...
Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer
Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) and Novocure (NASDAQ: NVCR) announced today that the pivotal, Phase 3 PANOVA-3 trial met its primary endpoi
www.businesswire.com
December 2, 2024 at 11:59 PM
myesmo.bsky.social
#ESMOGI25: #QualityofLife and #PainManagement data from the PANOVA-3 trial adds to efficacy results of combining TTFields with gemcitabine and nab-paclitaxel as a potential new option of care for locally advanced #PancreaticAdenocarcinoma
Read more in the #ESMODailyReporter
🔗 buff.ly/RvF9pgo
July 29, 2025 at 1:02 PM
onclive.bsky.social
🎙️On this episode of #OncLiveOnAir Philip A. Philip, MD, of @henryfordhealth.bsky.social discusses TTFields in pancreatic cancer and what phase 3 data has shown in locally advanced disease.

Listen here ➡️: www.onclive.com/view/explori...

#pancsm #oncology
Exploring the FDA Approval of Optune Pax and What It Means for Locally Advanced Pancreatic Cancer | OncLive
Philip A. Philip, MD, discusses TTFields in pancreatic cancer and what phase 3 data has shown in locally advanced disease.
www.onclive.com
September 28, 2026 at 5:38 PM
oncoassist.bsky.social
✨ #ASCO25 ✨
🚨BREAKING: Tumor Treating Fields (TTFields) extend overall survival in locally advanced pancreatic cancer

✅ PANOVA-3 shows OS, pain-free & progression-free benefits with no added toxicity

🔗 Read more: bit.ly/ONCOnews1J-2

#OncoAlert #OncEd #ONCOnews #CancerResearch
June 1, 2025 at 5:02 AM
onclive.bsky.social
What is the current role of TTFields in pancreatic cancer, and what may the future of this therapy look like? #pancsm #oncology

Philip A. Philip, MD shares insights that may shape clinical practice today and tomorrow ➡️: www.onclive.com/view/ttfield...
TTFields Add a New Dimension to the Changing Pancreatic Cancer Treatment Paradigm | OncLive
Philip A. Philip, MD, discusses TTFields, the recent approval of this modality in pancreatic cancer, and phase 3 data in locally advanced disease.
www.onclive.com
August 31, 2026 at 5:30 PM